Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination with Vorinostat in KRAS-Mutant Colorectal Cancer Models
Maria Pia Morelli(The University of Texas MD Anderson Cancer Center), Sabine Eckhardt(NILU)
Cited by 49
Related Papers
Survival improvement for patients with metastatic colorectal cancer over twenty years
|npj Precision Oncology|2023|172
Phase I/II trial of encorafenib, cetuximab, and nivolumab in patients with microsatellite stable, <i>BRAF</i><sup>V600E</sup> metastatic colorectal cancer.
|Journal of Clinical Oncology|2022|78
Atmospheric composition in the European Arctic and 30 years of the Zeppelin Observatory, Ny-Ålesund
|Atmospheric chemistry and physics|2022|66
Model evaluation of short-lived climate forcers for the Arctic Monitoring and Assessment Programme: a multi-species, multi-model study
|Atmospheric chemistry and physics|2022|45